The Clorox Company (NYSE:CLX) Shares Sold by Albion Financial Group UT

Albion Financial Group UT reduced its position in The Clorox Company (NYSE:CLX) by 0.9% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 32,105 shares of the company’s stock after selling 284 shares during the quarter. Albion Financial Group UT’s holdings in Clorox were worth $5,214,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. Brooklyn Investment Group increased its stake in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new position in Clorox during the 3rd quarter worth approximately $27,000. Continuum Advisory LLC increased its position in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Quarry LP lifted its holdings in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC purchased a new stake in shares of Clorox in the third quarter valued at approximately $48,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Clorox stock opened at $160.03 on Wednesday. The firm’s 50-day moving average is $164.16 and its two-hundred day moving average is $156.91. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market capitalization of $19.81 billion, a P/E ratio of 55.76, a P/E/G ratio of 2.95 and a beta of 0.42. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the company earned $0.49 EPS. Clorox’s revenue for the quarter was up 27.0% on a year-over-year basis. Equities analysts predict that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.05%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Analyst Ratings Changes

CLX has been the subject of several research analyst reports. DA Davidson increased their price objective on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and raised their price objective for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Evercore ISI lowered their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Barclays lowered their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.